Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.73 |
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6939710 | 0.98 | ALDH1A1 (0.76) | ALDH1A1TSHRSMN1; SMN2THRBTDP1 | |
| Methacrylic Acid SCHEMBL11696629 | 0.94 | ALDH1A1 (0.69) | ALDH1A1TSHRSMN1; SMN2THRBTDP1 | |
| SCHEMBL5614326 | 0.93 | ALDH1A1 (0.68) | ALDH1A1TSHRSMN1; SMN2THRBTDP1 | |
| SCHEMBL5475274 | 0.93 | ALDH1A1 (0.71) | ALDH1A1TSHRSMN1; SMN2THRBTDP1 | |
| SCHEMBL28328964 | 0.93 | ALDH1A1 (0.71) | ALDH1A1TSHRSMN1; SMN2THRBTDP1 | |
| SCHEMBL3363392 | 0.93 | ALDH1A1 (0.71) | ALDH1A1TSHRSMN1; SMN2THRBTDP1 | |
| SCHEMBL7530690 | 0.93 | ALDH1A1 (0.71) | ALDH1A1TSHRSMN1; SMN2THRBTDP1 | |
| SCHEMBL13517217 | 0.93 | ALDH1A1 (0.71) | ALDH1A1TSHRSMN1; SMN2THRBTDP1 | |
| SCHEMBL7528392 | 0.93 | ALDH1A1 (0.71) | ALDH1A1TSHRSMN1; SMN2THRBTDP1 | |
| SCHEMBL4779336 | 0.91 | ALDH1A1 (0.83) | ALDH1A1TSHRSMN1; SMN2THRBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4284861-A1 | LOW ODOR HEAT-EXPANDABLE MATERIALS | Zephyros Inc. (US) | 2023-12-06 | — | — | EP | claimed |
| WO-2022162058-A1 | LOW ODOR HEAT-EXPANDABLE MATERIALS | ZEPHYROS, INC. (US) | 2022-08-04 | — | — | WO | claimed |
| WO-2018149826-A1 | ACTIVATABLE POLYMER COMPOSITION COMPRISING AT LEAST TWO CARBOXYLIC ACIDS AS BLOWING AGENT | ZEPHYROS, INC. (US) | 2018-08-23 | — | — | WO | claimed |
| US-12552908-B2 | Thermally expandable compositions comprising a chemical blowing agent | SIKA TECHNOLOGY AG (CH) | 2026-02-17 | — | — | US | disclosed |
| US-12534587-B2 | Thermally expandable compositions comprising a chemical blowing agent | SIKA TECHNOLOGY AG (CH) | 2026-01-27 | — | — | US | disclosed |
| US-12522706-B2 | Thermally expandable compositions comprising an endothermic blowing agent | SIKA TECHNOLOGY AG (CH) | 2026-01-13 | — | — | US | disclosed |
| US-12460061-B2 | Expandable material with improved thermal insulation properties and use thereof | SIKA TECHNOLOGY AG (CH) | 2025-11-04 | — | — | US | disclosed |
| EP-4001352-B1 | EXPANDABLE MATERIAL WITH IMPROVED THERMAL INSULATION PROPERTIES AND USE THEREOF | SIKA TECH AG (CH) | 2025-09-17 | — | — | EP | disclosed |
| US-20240327589-A1 | Low Odor Heat-Expandable Materials | ZEPHYROS, INC. | 2024-10-03 | — | — | US | disclosed |
| CN-113825794-B | Thermally expandable composition comprising a chemical blowing agent | SIKA技术股份公司 | 2024-03-29 | — | — | CN | disclosed |
| US-20240093069-A1 | Activatable Polymer Composition Comprising At Least Two Carboxylic Acids as Blowing Agent | ZEPHYROS, INC. | 2024-03-21 | — | — | US | disclosed |
| WO-2021028599-A1 | THERMALLY EXPANDABLE COMPOSITIONS COMPRISING A CHEMICAL BLOWING AGENT | SIKA TECHNOLOGY AG (CH) | 2021-02-18 | — | — | WO | disclosed |
| EP-3778736-A1 | THERMALLY EXPANDABLE COMPOSITIONS COMPRISING A CHEMICAL BLOWING AGENT | SIKA TECHNOLOGY AG (CH) | 2021-02-17 | — | — | EP | disclosed |
| EP-3778737-A1 | THERMALLY EXPANDABLE COMPOSITIONS COMPRISING AN ENDOTHERMIC BLOWING AGENT | SIKA TECHNOLOGY AG (CH) | 2021-02-17 | — | — | EP | disclosed |
| EP-3778734-A1 | THERMALLY EXPANDABLE COMPOSITIONS COMPRISING A CHEMICAL BLOWING AGENT | SIKA TECHNOLOGY AG (CH) | 2021-02-17 | — | — | EP | disclosed |
| EP-3778735-A1 | THERMALLY EXPANDABLE COMPOSITIONS COMPRISING AN ENDOTHERMIC BLOWING AGENT | SIKA TECHNOLOGY AG (CH) | 2021-02-17 | — | — | EP | disclosed |
| EP-3778738-A1 | THERMALLY EXPANDABLE COMPOSITIONS COMPRISING A CHEMICAL BLOWING AGENT | SIKA TECHNOLOGY AG (CH) | 2021-02-17 | — | — | EP | disclosed |
| WO-2020249752-A1 | THERMALLY EXPANDABLE COMPOSITIONS COMPRISING A CHEMICAL BLOWING AGENT | SIKA TECHNOLOGY AG (CH) | 2020-12-17 | — | — | WO | disclosed |
| EP-3750951-A1 | THERMALLY EXPANDABLE COMPOSITIONS COMPRISING A CHEMICAL BLOWING AGENT | SIKA TECHNOLOGY AG (CH) | 2020-12-16 | — | — | EP | disclosed |
| WO-2018149826-A1 | ACTIVATABLE POLYMER COMPOSITION COMPRISING AT LEAST TWO CARBOXYLIC ACIDS AS BLOWING AGENT | ZEPHYROS, INC. (US) | 2018-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552908-B2 | Thermally expandable compositions comprising a chemical blowing agent | CA1, CA3, CA12 | ALDH1A1 1546/4885TSHR 4237/4885SMN1; SMN2 1536/4885 |
| US-12534587-B2 | Thermally expandable compositions comprising a chemical blowing agent | OGG1, GRN, TAF1 | ALDH1A1 3539/4885TSHR 4739/4885SMN1; SMN2 1499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.